The cannabinoid receptor agonist WIN 55,212-2 mesylate blocks the development of hyperalgesia produced by capsaicin in rats

Pain

Volumn 81, Issue 1-2, 1999, Pages 25-33

  Li, Jun ^a   Daughters, Randy S ^a   Bullis, Christopher ^b   Bengiamin, Rimon ^a   Stucky, Mark W ^a   Brennan, John ^b   Simone, Donald A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b HAMLINE UNIVERSITY   (United States)

Author keywords

Cannabinboids; CB1 receptor; Mechanical hyperalgesia; Pain; Thermal hyperalgesia

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID; CANNABINOID RECEPTOR; CAPSAICIN;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; HYPERALGESIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALGESICS; ANIMALS; BEHAVIOR, ANIMAL; CAPSAICIN; HEAT; HYPERALGESIA; MALE; MORPHOLINES; MOTOR ACTIVITY; NAPHTHALENES; PAIN; PHYSICAL STIMULATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 0032898832     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(98)00263-2     Document Type: Article

References (63)

1. Basbaum A.I., Fields H.L. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Ann. Rev. Neurosci. 7:1984;309-338.
2. Baumann T.K., Simone D.A., Shain C.N., LaMotte R.H. Neurogenic hyperalgesia: the search for primary cutaneous afferent fibers that contribute to capsaicin-induced pain and hyperalgesia. J. Neurophysiol. 66:1991;212-227.
3. Bloom A.S., Dewey W.L., Harris L.S., Brosius K.K. 9-nor-9b-Hydroxyhexahydrocanninol, a cannabiniod with potent antinociceptive activity: comparisons with morphine. J. Pharmacol. Exp. Ther. 200:1977;263-270.
4. 9-tetrahydrocannabinol in the mouse. Psychopharmacology. 57:1978;243-248.
5. 9-tetrahydrocannabinol in the rat and mouse. Psychopharmacolgia. 25:1972;275-280.
6. Calignano A., La Rana G., Giuffrida A., Piomelli D. Control of pain initiation by endogenous cannabinoids. Nature. 394:1998;277-281.
7. Campbell J.N., Meyer R.A., LaMotte R.H. Sensitization of myelinated nociceptive afferents that innervate monkey hand. J. Neurophysiol. 42:1979;1669-1679.
8. Carpenter S.E., Lynn B. Vascular and sensory responses of human skin to mild injury after topical treatment with capsaicin. Br. J. Pharmacol. 73:1981;755-758.
9. Chesher G.B., Dahl C.J., Everingham M., Jackson D.M., Marchant-Williams H., Starmer G.A. The effect of cannabinoids on intestinal motility and their antinociceptive effect in mice. Br. J. Pharmacol. 49:1973;588-594.
10. Compton D.R., Rice K.C., De Costa B.R., Razdan R.K., Melvin L.S., Johnson M.R., Martin B.R. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J. Pharm. Exp. Ther. 265:1993;218-226.
11. Cook A.J., Woolf C.J., Wall P.D., McMahon S.B. Dynamic receptive field plasticity in rat spinal dorsal horn following C-primary afferent input. Nature. 325:1987;151-153.
12. Culp W.J., Ochoa J.L., Cline M., Dotson R. Heat and mechanical hyperalgesia induced by capsaicin. Cross modality threshold modulation in human C nociceptors. Brain. 112:1989;1317-1331.
13. Daughters R.S., Li J., Bullis C., Bengiamin R., Brennan J., Hartman B.K., Simone D.A. Pain and hyperalgesia produced by capsaicin in rats are attenuated by a cannabinoid receptor agonist. Soc. Neurosci. Abstr. 23:1997;1805.
14. Devane W.A., Dysarz III F.A., Johnson M.R., Melvin L.S., Howlett A.C. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34:1988;605-613.
15. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1992;1946-1949.
16. Dunham N.W., Miya T.S. A note on a simple apparatus for detecting neurological deficit in rats and mice. J. Am. Pharm. Assoc. 46:1957;208-209.
17. Edsall S.A., Knapp R.J., Vanderah T.W., Roeske W.R., Consroe P., Yamamura H.I. Antisense oligodeoxynucleotide treatment to the brain cannabinoid receptor inhibits antinociception. NeuroReport. 7:1996;593-596.
18. Fitzgerald M., Lynn B. The sensitization of high threshold mechanoreceptors with myelinated axons by repeated heating. J. Physiol. (Lond.). 265:1977;549-563.
19. Fride E., Mechoulam R. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur. J. Pharmacol. 231:1993;313-314.
20. Gilchrist H.D., Allard B.L., Simone D.A. Enhanced withdrawal responses to heat and mechanical stimuli following intraplantar injection of capsaicin in rats. Pain. 67:1996;179-188.
21. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
22. Hardy J.D., Wolf H.G., Goodell H. Experimental evidence on the nature of cutaneous hyperalgesia. J. Clin. Invest. 29:1950;115-140.
23. Herkenham M., Lynn A.B., Little M.D., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Cannabinoid receptor localization in brain. Proc. Nat. Acad. Sci. USA. 87:1990;1932-1936.
24. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11:1991;563-583.
25. Herzberg U., Eliav E., Bennet G.J., Kopin J. The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain. Neurosci. Lett. 221:1997;157-160.
26. Hohmann A.G., Martin W.J., Tsou K., Walker J.M. Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2. Life Sci. 56:1995;2111-2118.
27. Hylden J.L.K., Nahin R.L., Traub R.J., Dubner R. Expansion of receptive fields of spinal lamina I projection neurons in rats with unilateral adjuvant-induced inflammation: the contribution of dorsal horn mechanisms. Pain. 37:1989;229-243.
28. Jansen E.M., Haycock D.A., Ward S.J., Seybold V.S. Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles. Brain Res. 575:1992;93-102.
29. 9-tetrahydrocannabinol (TCH). Pharmacologist. 13:1971;247.
30. 9-tetrahydrocannabinol in the dog, Psychopharmacologia, 35 (1974) 123-128.
31. Kenins P. Response of single nerves fibers to capsaicin applied to the skin. Neurosci. Lett. 29:1982;83-88.
32. Kinnard W.J. Jr., Carr C.J. A preliminary procedure for the evaluation of central nervous system depressants. J. Pharmacol. Exp. Ther. 258:1957;517-523.
33. Konietzny F., Hensel H. The effect of capsaicin on the response characteristic of human C-polymodal nociceptors. J. Therm. Biol. 8:1983;213-215.
34. LaMotte R.H., Thalhammer J.G., Torebjörk H.E., Robinson C.J. Peripheral neural mechanisms of cutaneous hyperalgesia following mild injury by heat. J. Neurosci. 2:1982;765-781.
35. LaMotte R.H., Thalhammer J.G., Robinson C.J. Peripheral neural correlates of magnitude of cutaneous pain and hyperalgesia: a comparison of neural events in monkey with sensory judgements in human. J. Neurophysiol. 50:1983;1-26.
36. LaMotte R.H., Shain C.N., Simone D.A., Tsai E.-F.P. Neurogenic hyperalgesia: psychophysical studies of underlying mechanisms. J. Neurophysiol. 66:1991;190-211.
37. LaMotte R.H., Lundberg L.E.R., Torebjörk H.E. Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin. J. Physiol. 448:1992;749-764.
38. Lewis T. Experiments relating to cutaneous hyperalgesia and its spread through somatic nerves. Clin. Sci. 2:1936;373-423.
39. Lichtman A.H., Martin B.R. Spinal and supraspinal components of cannabinoid-induced antinociception. J. Pharmacol. Exp. Ther. 258:1991;517-523.
40. Lichtman A.H., Martin B.R. The selective cannabinoid antagonist SR141716A blocks cannabinoid-induced antinociception in rats. Pharmacol. Biochem. Behav. 57:1997;7-12.
41. Martin B.R., Compton D.R., Thomas B.F., Prescott W.R., Little P.J., Razdan R.K., Johnson M.R., Melvin L.S., Mechoulam R., Ward S.J. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacol. Biochem. Behav. 40:1991;471-478.
42. Martin W.J., Patrick S.L., Coffin P.O., Tsou K., Walker J.M. An examination of the central sites of action of cannabinoid-induced antinociception in the rat. Life Sci. 56:1995;2103-2109.
43. Martin W.J., Hohmann A.G., Walker J.M. Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: Correlation between electrophysiological and antinociceptive effects. J. Neurosci. 16:1996;6601-6611.
44. Martin W.J., Tsou K., Walker J.M. Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla. Neurosci. Lett. 242:1998;33-36.
45. McMahon S.B., Wall P.W. Receptive fields of lamina I projection cells move to incorporate a nearby region of injury. Pain. 19:1983;235-247.
46. Meyer R.A., Campbell J.N. Myelinated afferents account for the hyperalgesia that follows a burn to the hand. Science. 213:1981;1527-1529.
47. 9-tetrahydrocannabinol as measured with the formalin test. Eur. J. Pharmacol. 61:1980;313-315.
48. Reynolds J.R. Therapeutic uses and toxic effects of Cannabis indica. Lancet. 1:1890;637.
49. Rinaldi-Carmona M., Barth F., Héaulme M., Shire D., Calandra B., Congy C., Martinez S., Maruani J., Néliat G., Caput D., Ferrara P., Soubrié P., Breliére J.C., Le Fur G. SR141716A, a potent and selective antagonist of the brain cannabiniod receptor. FEBS Lett. 350:1994;240-244.
50. Richardson, J.D., Aanonson, L. and Hargreaves, K.M., SR141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice, Eur. J. Pharmacol., 319 (1997a) R3-4.
51. Richardson, J.D., Kilo, S. and Hargreaves, K.M., Cannabinoids act at peripheral CB1 receptors to block thermal hyperalgesia and edema, Soc. Neurosci. Abstr., 23 (1997b) 1815.
52. Richardson J.D., Aanonson L., Hargreaves K.M. Hypoactivity of the cannabinoid system results in NMDA-dependent hyperalgesia. J. Neurosci. 18:1998;451-457.
53. Sanders J., Jackson D.M., Starmer G.A. Interactions among the cannabinoids in the antagonism of the abdominal constriction response in the mouse. Psychopharmacology. 61:1979;281-285.
54. Simone D.A., Baumann T.K., LaMotte R.H. Dose-dependent pain and mechanical hyperalgesia in humans after intradermal injection of capsaicin. Pain. 38:1989;99-107.
55. Simone D.A., Sorkin L.S., Oh U., Chung J.M., Owens C., LaMotte R.H., Willis W.D. Neurogenic hyperalgesia: central neural correlates in responses of spinothalamic tract neurons. J. Neurophysiol. 66:1991;228-246.
56. Simone D.A., Li J., Daughters R.S. The cannabinoid receptor agonist WIN 55,212-2 blocks sensitization of rat spinal dorsal horn neurons produced by capsaicin. Soc. Neurosci. Abstr. 23:1997;447.
57. Sofia R.D., Nalepa S.D., Harakal J.J., Vassar H.B. Anti-edema and analgesic properties of delta-9-tetrahydrocannabinol (THC). J. Pharmacol. Exp. Ther. 186:1973;646-655.
58. Szolcsáyni J. A pharmacological approach to elucidation of the role of different nerve fibers and receptor endings in mediation of pain. J. Physiol. (Paris). 73:1977;251-259.
59. Szolcsáyni J., Anton F., Reeh P.W., Handwerker H.O. Selective excitation by capsaicin of mechano-heat sensitive nociceptors in rat skin. Brain Res. 446:1988;262-268.
60. Torebjörk H.E., Lundberg L.E.R., LaMotte R.H. Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans. J. Physiol. (Lond.). 448:1992;765-780.
61. Woolf C.J., King A.E. Dynamic alteration in the cutaneous mechanoreceptive fields of dorsal horn neurons in the rat spinal cord. J. Neurosci. 10:1990;2717-2726.
62. Yaksh T.L. The antinociceptive effects of intrathecally administered levonantradol and desacetyllevonantradol in the rat. J. Clin. Pharmacol. 21:1981;334S-340S.
63. Yaksh T.L., Rudy T.A. Narcotic analgetics: CNS sites and mechanisms of action as revealed by intracerebral injection techniques. Pain. 4:1978;299-359.